Linda Burkly
Evp, Chief Scientific Officer at Editas Medicine, Inc. (EDIT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $20K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 4SEC | EDITEditas Medicine, Inc. | Sell Plan | 70961,660 held (−1%) | $3.04 | $2K | -4.6% |
| Jul 29SEC | EDITEditas Medicine, Inc. | Sell Plan | 4,92862,369 held (−7%) | $2.67 | $13K | +8.6% |
| Jun 5SEC | EDITEditas Medicine, Inc. | Sell Plan | 73167,297 held (−1%) | $2.70 | $2K | +7.4% |
| Mar 4SEC | EDITEditas Medicine, Inc. | Sell Plan | 74968,028 held (−1%) | $2.02 | $2K | +43.6% |
| Dec 4SEC | EDITEditas Medicine, Inc. | Sell Plan | 71368,777 held (−1%) | $2.15 | $2K | +34.9% |
- Sell
Evp, Chief Scientific Officer Linda Burkly sold $2K of EDIT at $3.04 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Scientific Officer Linda Burkly sold $13K of EDIT at $2.67 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Scientific Officer Linda Burkly sold $2K of EDIT at $2.70 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Scientific Officer Linda Burkly sold $2K of EDIT at $2.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Scientific Officer Linda Burkly sold $2K of EDIT at $2.15 — pre-scheduled 10b5-1 plan sale.